CASR and ADH1: Integrating Biology and Genetic Screening
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
The Future of ADH1 - Looking at Emergent Treatments
Emerging Therapeutics in ADH1: Progress in Precision Medicine
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
Therapeutic Options for ADH1 and Hypoparathyroidism
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.